Rapid estrogen actions in the cardiovascular system

Annals of the New York Academy of Sciences

Volumn 1089, Issue , 2006, Pages 424-430

  Simoncini, Tommaso ^a   Mannella, Paolo ^a   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Endothelial cells; Estrogen; Estrogen receptors; Nongenomic signaling

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; MESSENGER RNA; STEROID RECEPTOR; ESTROGEN RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CELL GROWTH; CELL MIGRATION; CONFERENCE PAPER; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENITAL SYSTEM; GENOMICS; HEART PROTECTION; MODULATION; MOLECULAR DYNAMICS; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; REVIEW;

ANIMALIA;

ANIMALS; CARDIOVASCULAR SYSTEM; ESTROGENS; HUMANS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 33847770935     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1386.001     Document Type: Conference Paper

References (27)

1. TRUSS, M. & M. BEATO. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14: 459-479.
2. SIMONCINI, T. & A. R. GENAZZANI. 2003. Non-genomic actions of sex steroid hormones. Eur. J. Endocrinol. 148: 281-292.
3. PEDRAM, A., M. RAZANDI & E. R. LEVIN. 2006. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20: 1996-2009.
4. NAKAJIMA, T. et al. 1995. 17beta-estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur. J. Pharmacol. 294: 625-635.
5. KELLY, M. J. et al. 1999. Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64: 64-75.
6. MIGLIACCIO, A. et al. 1996. Tyrosine kinase/p21ras/MAP- kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15: 1292-1300.
7. ARONICA, S.M., W.L. KRAUS & B. S. KATZENELLENBOGEN.1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91: 8517-8521.
8. LE MELLAY, V., B. GROSSE & M. LIEBERHERR. 1997. Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272: 11902-11907.
9. SIMONCINI, T. et al. 2000. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541.
10. SIMONCINI, T., E. RABKIN & J. K. LIAO. 2003. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 23: 198-203.
11. LEVIN, E.R. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19: 1951-1959.
12. SIMONCINI, T. & A. R. GENAZZANI. 2000. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin. Endocrinol. Metab. 85: 2966-2969.
13. SIMONCINI, T. et al. 2002. Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology 143: 2052-2061.
14. SIMONCINI, T., A.R. GENAZZANI & J. K. LIAO. 2002. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 105: 1368-1373.
15. SIMONCINI, T. et al. 2004. Tibolone activates nitric oxide synthesis in human endothelial cells. J. Clin. Endocrinol. Metab. 89: 4594-4600.
16. SIMONCINI, T. et al. 2005. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas 50: 247-258.
17. SIMONCINI, T. et al. 2005. Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause 12: 69-77.
18. SIMONCINI, T., R. De Caterina & A. R. GENAZZANI. 1999. Selective estrogen receptor modulators: different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells. J. Clin. Endocrinol. Metab. 84: 815-818.
19. SIMONCINI, T. et al. 2000. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 87: 19-25.
20. SIMONCINI, T. & A. R. GENAZZANI. 2000. Direct vascular effects of estrogens and selective estrogen receptor modulators. Curr. Opin. Obstet. Gynecol. 12: 181-187.
21. SIMONCINI, T. & A. R. GENAZZANI. 2000. Tibolone inhibits leukocyte adhesion molecule expression in human endothelial cells. Mol. Cell. Endocrinol. 162: 87-94.
22. SIMONCINI, T. et al. 2006. Estrogen receptor {alpha} interacts with G{alpha}13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho Kinase/Moesin pathway. Mol. Endocrinol. 20: 1756-1771.
23. MENDELSOHN, M.E. & R. H. KARAS. 1999. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340: 1801-1811.
24. MENDELSOHN, M.E. & R. H. KARAS. 2005. Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587.
25. CHAMBLISS, K.L. & P. W. SHAUL. 2002. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23: 665-686.
26. PEDRAM, A. et al. 2002. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J. Biol. Chem. 277: 50768-50775.
27. Hafezi-Moghadam, A. et al. 2002. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat. Med. 8: 473-479.